quality Vacuum Blood Collection System & Medical Laboratory Consumables manufacturer

The China Import and Export Fair, commonly referred to as Canton Fair, represents one of the grandest events on the global trade calendar. Since 1957 when its first edition took place in Guangzhou China, this biannual fair has expanded into an enormous platform for both imports and exports from across industries - featuring products from numerous sectors every spring and autumn respectively. Co-hosted by both Ministry of Commerce of People's Republic of China (PRC) as well as People's Government of Guangdong Province; organizational efforts provided by China Foreign Trade Centre; every spring/autumn event hosted from Guangzhou by these entities with organizational efforts by China Foreign Trade Centre being responsible for planning efforts.   The coming 135th Canton Fair will mark another important moment in its long and distinguished history. Set for spring 2024 and hosted in Guangzhou's sprawling Canton Fair Complex, this edition promises to build on past traditions by encouraging international trade and business interactions. Carefully organized into three phases that each focus on specific industries or products so attendees can efficiently navigate and maximize participation at this global trade event.     Phase 3 From May 01- 05 Personal Care Appliances, Bathroom Products, Medicines, Health Products and Medical Devices, Pet Products, Maternity and Baby Products, Toys, Children's Clothing, Men's and Women's Clothing, Sportswear and Casual Wear, Underwear, Fur, Leather, Down and Related, Products, Clothing Accessories and Fittings, Home Textiles, Textile Raw Materials and Fabrics, Carpets and Tapestries, Shoes, Office Supplies, Bags and Suitcases, Sports and Tourism Leisure Products, Food,Rural Revitalization.   Our booth: Hall 10, 10.2F24.     We sincerely invite you to visit our booth and experience the quality of our products firsthand.

  A central venous catheter (CVC), also known as a central line (c-line), central venous line, or central venous access catheter, is a catheter placed into a large vein. It is a form of venous access. Placement of larger catheters in more centrally located veins is often needed in critically ill patients, or in those requiring prolonged intravenous therapies, for more reliable vascular access. These catheters are commonly placed in veins in the neck (internal jugular vein), chest (subclavian vein or axillary vein), groin (femoral vein), or through veins in the arms (also known as a PICC line, or peripherally inserted central catheters). Central lines are used to administer medication or fluids that are unable to be taken by mouth or would harm a smaller peripheral vein, obtain blood tests (specifically the "central venous oxygen saturation"), administer fluid or blood products for large volume resuscitation, and measure central venous pressure. The catheters used are commonly 15–30 cm in length, made of silicone or polyurethane, and have single or multiple lumens for infusion.   Medical uses     The following are the major indications for the use of central venous catheters:   Difficult peripheral venous access – central venous catheters may be placed when it is difficult to gain or maintain venous access peripherally (e.g. obesity, scarred veins from prior cannulations, agitated patient). Delivery of certain medications or fluids – medications such as vasopressors (e.g., norepinephrine, vasopressin, phenylephrine etc.), chemotherapeutic agents, or hypertonic solutions are damaging to peripheral veins and often require placement of a central line. Additionally, catheters with multiple lumens can facilitate the delivery of several parenteral medications simultaneously. Prolonged intravenous therapies – parenteral medications that must be delivered for extended periods of time (more than a few days) such as long-term parenteral nutrition, or intravenous antibiotics are administered through a central line. Specialized treatment – interventions such as hemodialysis, plasmapheresis, transvenous cardiac pacing, and invasive hemodynamic monitoring (e.g. pulmonary artery catheterization) require central venous access.   There are no absolute contraindications to the use of central venous catheters.Relative contraindications include: coagulopathy, trauma or local infection at the placement site, or suspected proximal vascular injury.However, there are risks and complications associated with the placement of central lines, which are addressed below.     What should I pay attention to during the CVC insertion process?     Infection control: Prior to CVC insertion, healthcare providers should practice proper hand hygiene and adhere to strict infection control measures. This includes wearing sterile gloves, masks, caps, and gowns, using sterile drapes to cover the patient, and maintaining sterile technique throughout the insertion process.   Appropriate site selection: Selecting the appropriate insertion site, such as subclavian vein, internal jugular vein, or femoral vein, based on the patient's specific condition and needs. Proper site selection can improve the success rate of catheter insertion and reduce the risk of complications.   Local anesthesia: Local anesthesia is typically administered prior to CVC insertion to minimize patient discomfort and pain. Anesthetic agents are commonly used through local injection or topical anesthesia.   Implement sterile technique: During CVC insertion, healthcare providers should adhere to sterile technique, including using sterile puncture needles and guidewires, avoiding contamination of the insertion site, and ensuring all instruments and materials used are sterile. Monitoring and guidance: Real-time monitoring devices, such as ultrasound, can aid in determining the correct insertion position. Guidewires are used to navigate the catheter through the blood vessels.   Ensure patency and securement: After CVC insertion, ensure proper blood return and perform an X-ray to confirm the correct position of the catheter. Additionally, use appropriate securement devices, such as sutures or transparent dressings, to secure the CVC in place and prevent dislodgement.   Infection prevention: Once the CVC is inserted, take appropriate infection prevention measures, such as regular dressing changes, maintaining cleanliness and dryness at the insertion site, and adhering to the recommended time frame for CVC replacement.  

CPAP introduction:   An implant for obstructive sleep apnea — a serious sleep malady in which breathing stops for 10 seconds to two minutes many times an hour each night — works best in people who are overweight but not severely obese, a new study found. To qualify for the device, called a hypoglossal nerve stimulator, a person over 18 diagnosed with moderate-to-severe obstructive sleep apnea must be unable to adapt or refuse to wear a continuous positive airway pressure, or CPAP, machine, the gold standard treatment for obstructive sleep apnea.     CPAP stands for Continuous Positive Airway Pressure. It is a non-invasive medical treatment commonly used for individuals with sleep apnea, a condition characterized by interrupted breathing during sleep.   A CPAP machine delivers a constant flow of air pressure through a mask worn over the nose or both the nose and mouth. The air pressure helps keep the airways open, preventing pauses in breathing and ensuring a continuous oxygen supply throughout the night. By maintaining a steady airflow, CPAP effectively reduces or eliminates snoring, improves sleep quality, and alleviates the symptoms of sleep apnea.   CPAP machines typically consist of a motor that generates airflow, a humidifier that adds moisture to the air to prevent dryness, a mask or interface that fits over the face, and tubing that connects these components. The machine can be adjusted to deliver the appropriate air pressure prescribed by a healthcare professional based on the severity of the individual's sleep apnea.   It's important to note that CPAP therapy requires a diagnosis of sleep apnea and a prescription from a qualified healthcare provider. The specific settings and adjustments of the CPAP machine should be determined by a sleep specialist or respiratory therapist to ensure its effectiveness and safety for the individual using it.     CPAP replacement works well for the overweight, not obese, study finds.   The new study, published Thursday in the journal JAMA Otolaryngology — Head & Neck Surgery, looked at the body mass index of 76 patients who had received the implant, said senior author Dr. Eric Landsness, an assistant professor of neurology and sleep medicine at Washington University School of Medicine in St. Louis.   Currently, the implant surgery, which costs between $50,000 and $100,000, is approved and covered by Medicare and many insurance companies for people with a BMI of up to 40.   However, “we found for people with a BMI of more than 32, the device might be unsuccessful up to 75% of the time,” Landsness said. “It was a linear relationship: For each unit increase in BMI beyond 32, the odds of successful treatment decreased by approximately 17%.”   As currently defined, a BMI between 18.5 and 24.9 is a healthy weight, between 25 and 29.5 is overweight, between 30 and 34.9 is obese, between 35 and 39.5 is class 2 obesity, and anything over 40 is “severe” or class 3 obesity, which used to be called morbid obesity. People are considered underweight if their BMI is lower than 18.5.   The study also found the implant was less successful for people who slept on their backs, or what is called the supine position.   Yet many people with the condition have no idea they are denying their brains and bodies life-sustaining oxygen, often going undiagnosed until a sleep partner complains of excessive snoring or gasping during sleep, two telltale signs.   “People wake up just enough to start breathing when this happens but often not enough to regain consciousness,” Landsness said. “They can go on like that for years without realizing why they have a lack of focus, low energy and excessive sleepiness during the day.”   New solutions to treat obstructive sleep apnea are desperately needed, so the stimulator’s advent was welcome news to doctors desperate to offer their patients a solution, Landsness said.     “As an alternative treatment for sleep apnea, this hypoglossal nerve stimulation surgery could revolutionize some people’s lives,” he said. “I’ve had patients cry with joy after they have recovered because they have tried so hard and failed with CPAP, and we finally found something that works for them.   “However, it seems a person’s weight seems to be an important factor that predicts whether or not they will respond successfully to the treatment,” he said. “As a sleep doctor, I want this treatment to be given to patients, but I want it to be given to the right patients, the ones who will benefit the most.”